Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients
- 24 April 2003
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 61 (3) , 261-264
- https://doi.org/10.1016/s0361-9230(03)00089-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Release of Glial Tissue–Specific Proteins After Acute StrokeStroke, 2000
- Traumatic Brain Damage: Serum S-100 Protein Measurements Related to Neuroradiological FindingsJournal of Neurotrauma, 2000
- S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA InfarctionStroke, 1997
- Neuron-specific enolase as an aid to outcome prediction in head injuryBritish Journal Of Neurosurgery, 1996
- Myelin Basic Protein in the Cerebrospinal Fluid of Patients with Brain TumorsNeurosurgery, 1994
- CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisoloneActa Neurologica Scandinavica, 1992
- Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction.Stroke, 1991
- Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathologyClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- CSF myelin basic protein in multiple sclerosisActa Neurologica Scandinavica, 1985